Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CDC25B | P30305 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23660007 | 0.94 | ALDH1A1 (0.51) | ALDH1A1HSD17B10CYP3A4HPGDEPHX2 | |
| SCHEMBL29303808 | 0.90 | ALDH1A1 (0.50) | ALDH1A1HSD17B10CYP3A4HPGDEPHX2 | |
| SCHEMBL23658604 | 0.90 | ALDH1A1 (0.50) | ALDH1A1HSD17B10CYP3A4HPGDEPHX2 | |
| SCHEMBL17701124 | 0.90 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CYP3A4HPGDEPHX2 | |
| SCHEMBL24056320 | 0.88 | ALDH1A1 (0.56) | ALDH1A1HSD17B10CYP3A4HPGDEPHX2 | |
| SCHEMBL16657696 | 0.88 | ALDH1A1 (0.70) | ALDH1A1HSD17B10CYP3A4HPGDMAPT | |
| SCHEMBL23822230 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HSD17B10CYP3A4HPGDMAPT | |
| SCHEMBL18201522 | 0.86 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CYP3A4HPGDMAPT | |
| SCHEMBL30800493 | 0.86 | ALDH1A1 (0.48) | ALDH1A1HSD17B10CYP3A4HPGDEPHX2 | |
| SCHEMBL25568868 | 0.86 | ALDH1A1 (0.53) | ALDH1A1HSD17B10CYP3A4HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023002447-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2023003403-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2022250244-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2022-12-01 | — | — | WO | disclosed |
| US-10800969-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2020-10-13 | — | — | US | disclosed |
| US-20180148641-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10800969-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, PER2 | ALDH1A1 735/4885HSD17B10 2911/4885CYP3A4 57/4885 |
| US-20180148641-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | ALDH1A1 854/4885HSD17B10 2843/4885CYP3A4 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.